Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Bañuls (Valencia, Spain), S. Castillo (Valencia, Spain), M. Magallón (Valencia, Spain), D. Pellicer (Valencia, Spain), S. Bondia (Valencia, Spain), M. Navarro-García (Valencia, Spain), C. González (Valencia, Spain), F. Dasí (Valencia, Spain). Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients. 668

Member's Comments

No comment yet.

Related content which might interest you: Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Immunomodulation capacity of alpha-1 antitrypsin in regulation of CD14 molecules expression and secretion in human monocytes in vitro Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 microRNA regulation of the alpha-1 antitrypsin gene Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010 The correction of monocyte-derived neohepatocytes from alpha1 antitrypsin deficient patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Long-term changes of elastin breakdown products in alpha-1 antitrypsin deficiency Source: Eur Respir J 2007; 30: Suppl. 51, 139s Year: 2007 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004 Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003 Hypoxia induces proinflammatory cytokines production in alpha-1 antitrypsin deficiency patients Source: Virtual Congress 2021 – Pathogenic progress in airway diseases Year: 2021 Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Alpha-1 antitrypsin: functional analysis of novel variants Source: Research Seminar 2014 - Protein quality control in lung disease Year: 2014 Neutrophil elastase gene expression and relation with lung function in Alpha-1 Antitrypsin deficiency patients. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017